Bortezomib Terminated Phase 2 Trials for Lymphoma, Mucosa-Associated Lymphoid Tissue Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00210392VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy